Literature DB >> 22992529

Tetralogy of Fallot: fetal diagnosis to surgical correction.

M Monaco1, I Williams.   

Abstract

Tetralogy of Fallot is one of the most common forms of cyanotic congenital heart disease. The diagnosis consists of four main anatomic features: a large ventricular septal defect (anterior malaligned), overriding aorta, right ventricular outflow obstruction and right ventricular hypertrophy. The refinement of fetal screening and echocardiography has led to an increase in prenatal diagnosis. Prenatal diagnosis along with the recognition of extracardiac anomalies and genetic abnormalities, including 22q11 deletion, sets the framework for prenatal counseling and can help predict the postnatal course and surgical repair. After birth, the degree of cyanosis and the presence of other extracardiac and cardiac abnormalities will direct the timing of surgical repair. Full surgical repair within the first year of life, either primary or after a palliative procedure, is the mainstay of therapy. Our understanding of the consequences of prior era surgeries and the detrimental effects of long standing pulmonary insufficiency has led to newer surgical and interventional techniques. Tetralogy of Fallot is a lifelong disease that requires careful follow up through adulthood with the potential for additional surgical and interventional procedures later in life.

Entities:  

Mesh:

Year:  2012        PMID: 22992529

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  2 in total

1.  Tetralogy of Fallot - Clinical Course and Treatment as a Mirror of Contemporary Cardiology/Cardiac Surgery Development in Correction of Congenital Heart Disease in the Adults.

Authors:  Edin Begic; Zijo Begic; Dzenan Jahic; Enisa Hodzic
Journal:  Med Arch       Date:  2018-06

2.  Transcriptome analysis defines myocardium gene signatures in children with ToF and ASD and reveals disease-specific molecular reprogramming in response to surgery with cardiopulmonary bypass.

Authors:  Federica Raggi; Davide Cangelosi; Pamela Becherini; Fabiola Blengio; Martina Morini; Massimo Acquaviva; Maria Luisa Belli; Giuseppe Panizzon; Giuseppe Cervo; Luigi Varesio; Alessandra Eva; Maria Carla Bosco
Journal:  J Transl Med       Date:  2020-01-10       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.